Jump Financial, LLC Vincerx Pharma, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.0 - $0.0 $0 - $0	-12,580 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.0 - $0.0 $0 - $0	12,580 New	12,580 $50,000
Q3 2021 Nov 12, 2021	SELL	$0.0 - $0.0 $0 - $0	-20,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.0 - $27.0 $0 - $540,000	20,000 New	20,000 $260,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.